Denovo
Pre-Approval PRO BETAStale Activity
No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 6/29/2022
Pipeline by Phase
Therapeutic Focus
Clinical Trials (20)
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™
Started: 3/20/2018
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Started: 12/16/2020
A Study of LY2140023 in Patients With Schizophrenia
Started: 3/1/2011
A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients
Started: 4/1/2011
A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia
Started: 12/1/2011
A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD
Started: 6/29/2022
A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients
Started: 3/1/2009
A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms
Started: 1/1/2010
A Comparator Study of LY2140023 Versus Placebo in Schizophrenia Patients
Started: 3/1/2010
A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia
Started: 6/1/2012
A Study of Safety and Tolerability in Subjects With Schizophrenia
Started: 5/1/2011
A Study of LY2140023 in Hepatically-Impaired Participants
Started: 11/1/2011
The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects
Started: 9/1/2011